CDC links hepatitis C to infusion therapy
CDC links hepatitis C to infusion therapy
The Centers for Disease Control and Prevention (CDC) in Atlanta recently reported that home health agencies should take extra precautions in educating patients and caregivers about the proper techniques for home infusion therapy.
Caregivers should be taught to wear gloves and follow universal precautions to prevent the spread of hepatitis C virus (HCV) and other infectious diseases.
Also, the families’ infection control practices and infusion therapy procedures should be regularly evaluated at home during follow-up visits with nurses and other health care professionals who have specific training in such practices. Caregivers need to be told that any needlestick incidents must be reported to the home health agency or the physician.
The recommendation followed disclosure that a four-year-old child with hemophilia contracted HCV during exposure to the mother’s blood during infusion of clotting-factor concentrate.1
The mother had a history of having injected illegal drugs and has HCV-infected blood.
The CDC report says the child’s mother had begun to administer clotting-factor concentrate to the child beginning in November 1994. She had been trained by a nurse employed by a home health care agency.
Infection probably occurred between February 1995 and June 1996 when the mother administered the concentrate to the boy 13 times. The mother reported that until May 1996, the boy resisted treatment and three other people had to restrain him. The infusions took three hours to complete.
Twice, the mother said she had pricked her finger and drew blood while attempting an infusion. She didn’t wear gloves. CDC investigators ruled out other sources of transmission.
CDC scientists analyzed the HCV strains in the mother and child and found that they were identical.
Reference
1. Centers for Disease Control and Prevention. Transmission of hepatitis C virus infection associated with home infusion therapy for hemophilia. MMWR 1997; 46:26.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.